{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:02:01Z","timestamp":1791169321898,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12012-018-9470-2","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T10:44:45Z","timestamp":1530528285000},"page":"23-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy"],"prefix":"10.1007","volume":"19","author":[{"given":"Basant","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udit","family":"Chaube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-5452","authenticated-orcid":false,"given":"Bhoomika M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"issue":"4","key":"9470_CR1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","volume":"91","author":"R Anan","year":"1995","unstructured":"Anan, R., Nakagawa, M., Miyata, M., Higuchi, I., Nakao, S., Suehara, M., et al. (1995). Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation, 91(4), 955\u2013961.","journal-title":"Circulation"},{"key":"9470_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0008-6363(03)00329-8","volume":"59","author":"C Andrews","year":"2003","unstructured":"Andrews, C., Ho, P., Dillmann, W., Glembotski, C., & McDonoughc, P. (2003). The MKK6\u2013p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT. Cardiovascular Research, 59, 46\u201356.","journal-title":"Cardiovascular Research"},{"key":"9470_CR3","doi-asserted-by":"publisher","first-page":"e95641","DOI":"10.1371\/journal.pone.0095641","volume":"9","author":"R Anton","year":"2014","unstructured":"Anton, R., Bauer, S. M., Keck, P., & Laufer, P. (2014). A p38 Substrate-Specific MK2-EGFP translocation assay for identification and validation of new p38 inhibitors in living cells: A comprising alternative for acquisition of cellular p38 inhibition. PLoS ONE, 9, e95641.","journal-title":"PLoS ONE"},{"key":"9470_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1096\/fasebj.14.2.312","volume":"14","author":"G Barja","year":"2000","unstructured":"Barja, G., & Herrero, A. (2000). Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heat and brain of mammals. The FASEB Journal, 14, 312\u2013318.","journal-title":"The FASEB Journal"},{"key":"9470_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen Jr. (2010). Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies. Pharmacology & Therapeutics, 128, 191\u2013227.","journal-title":"Pharmacology & Therapeutics"},{"key":"9470_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/cns.12175","volume":"19","author":"A Borah","year":"2013","unstructured":"Borah, A., Paul, R., Choudhury, S., Choudhury, A., Bhuyan, B., Talukdar, D., A., et al (2013). Neuroprotective potential of silymarin against CNS disorders: Insight into the pathways and molecular mechanisms of action. CNS Neuroscience Therapeutics, 19, 847\u2013853.","journal-title":"CNS Neuroscience Therapeutics"},{"key":"9470_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","volume":"151","author":"DI Buckley","year":"2009","unstructured":"Buckley, D. I., Fu, R., Freeman, M., Rogers, K., & Helfand, M. (2009). C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analyses for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 151, 483\u2013495.","journal-title":"Annals of Internal Medicine"},{"key":"9470_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/cvr\/cvq239","volume":"88","author":"H Bugger","year":"2010","unstructured":"Bugger, H., & Abel, E. D. (2010). Mitochondria in the diabetic heart. Cardiovascular Research, 88, 229\u2013240.","journal-title":"Cardiovascular Research"},{"issue":"2\u20133","key":"9470_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cbi.2005.08.005","volume":"156","author":"PN Chen","year":"2005","unstructured":"Chen, P. N., Hsieh, Y. S., Chiou, H. L., & Chu, S. C. (2005). Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chemico-Biological Interactions, 156(2\u20133), 141\u2013150.","journal-title":"Chemico-Biological Interactions"},{"key":"9470_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","volume":"108","author":"DF Dai","year":"2011","unstructured":"Dai, D. F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintron, M., Chen, T., et al. (2011). Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circulation Research, 108, 837\u2013846.","journal-title":"Circulation Research"},{"key":"9470_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","volume":"18","author":"NS Dhalla","year":"2000","unstructured":"Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000). Role of oxidative stress in cardiovascular diseases. Journal of Hypertension, 18, 655\u2013673.","journal-title":"Journal of Hypertension"},{"issue":"5","key":"9470_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1161\/CIRCRESAHA.110.226803","volume":"108","author":"JG Dickhout","year":"2011","unstructured":"Dickhout, J. G., Carlisle, R. E., & Austin, R. C. (2011). Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: Endoplasmic reticulum stress as a mediator of pathogenesis. Circulation Research, 108(5), 629\u2013642.","journal-title":"Circulation Research"},{"key":"9470_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ejmech.2014.07.027","volume":"84","author":"A Elkamhawy","year":"2014","unstructured":"Elkamhawy, A., Lee, J., Park, B. G., Park, I., Pae, A. N., & Roh, E. J. (2014). Novel quinazoline-urea analogues as modulators for A\u03b2-induced mitochondrial dysfunction: Design, synthesis, and molecular docking study. European Journal of Medicinal Chemistry, 84, 466\u2013475.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"9470_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey, N., & Olson, E. N. (2003). Cardiac hypertrophy: The good, the bad, and the ugly. Annual Review of Physiology, 65, 45\u201379.","journal-title":"Annual Review of Physiology"},{"issue":"9","key":"9470_CR15","doi-asserted-by":"publisher","first-page":"e0139208","DOI":"10.1371\/journal.pone.0139208","volume":"10","author":"E Gabrielov\u00e1","year":"2015","unstructured":"Gabrielov\u00e1, E., Zholobenko, A. V., Barto\u0161\u00edkov\u00e1, L., Ne\u010das, J., & Modriansky, M. (2015). Silymarin constituent 2,3-dehydrosilybin triggers reserpine-sensitive positive inotropic effect in perfused rat heart. PLoS ONE, 10(9), e0139208.","journal-title":"PLoS ONE"},{"key":"9470_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcpt.12088","volume":"113","author":"M Gharagozloo","year":"2013","unstructured":"Gharagozloo, M., Jafari, S., Esmaeil, N., Javid, E. N., Bagherpour, B., & Rezaei, A. (2013). Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: The impact on T cell proliferation and cytokine production. Basic & Clinical Pharmacology & Toxicology, 113, 209\u2013214.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"9470_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/AC.67.2.2154211","volume":"67","author":"BR Goyal","year":"2012","unstructured":"Goyal, B. R., & Mehta, A. A. (2012). Beneficial role of spironolactone, telmisartan and their combination on isoproterenol induced cardiac hypertrophy. Acta Cardiologica, 67, 203\u2013211.","journal-title":"Acta Cardiologica"},{"key":"9470_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/0960327112450885","volume":"32","author":"BR Goyal","year":"2013","unstructured":"Goyal, B. R., & Mehta, A. A. (2013). Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfunction. Human & Experimental Toxicology, 32, 571\u2013590.","journal-title":"Human & Experimental Toxicology"},{"key":"9470_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-008-9772-y","volume":"314","author":"BR Goyal","year":"2008","unstructured":"Goyal, B. R., Mesariya, P., Goyal, R. K., & Mehta, A. A. (2008). Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats. Molecular and Cellular Biochemistry, 314, 123\u2013131.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"9470_CR20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1734-1140(11)70611-9","volume":"63","author":"BR Goyal","year":"2011","unstructured":"Goyal, B. R., Parmar, K., Goyal, R. K., & Mehta, A. A. (2011). Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type-2 diabetic rats. Pharmacological Reports, 63, 956\u2013966.","journal-title":"Pharmacological Reports"},{"key":"9470_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000497705","volume":"19","author":"BR Goyal","year":"2011","unstructured":"Goyal, B. R., Patel, M. M., & Bhadada, S.\u00a0V. (2011). Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril on diabetes induced cardiovascular complications in type 1 diabetes in rats. International Journal of Diabetes and Metabolism, 19, 11\u201318.","journal-title":"International Journal of Diabetes and Metabolism"},{"key":"9470_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/FJC.0b013e3181be75cc","volume":"54","author":"BR Goyal","year":"2009","unstructured":"Goyal, B. R., Solanki, N., Goyal, R. K., & Mehta, A. A. (2009). Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes. Journal of Cardiovascular Pharmacology, 54, 502\u2013509.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9470_CR23","first-page":"286290","volume":"33","author":"AY Hakan","year":"2002","unstructured":"Hakan, A. Y., Arsava, M., & Okay, S. (2002). Creatine kinase-MB elevation after stroke is not cardiac in origin. Stroke 33, 286\u2013290.","journal-title":"Stroke"},{"key":"9470_CR24","doi-asserted-by":"publisher","first-page":"R1684","DOI":"10.1152\/ajpregu.00219.2007","volume":"293","author":"JW Horton","year":"2007","unstructured":"Horton, J. W., Tan, J., White, J., & Maass, D. (2007). Burn injury decreases myocardial Na- K-ATPase activity: Role of PKC inhibition. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 293, R1684\u2013R1692.","journal-title":"American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"},{"issue":"5","key":"9470_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/1028602042000324862","volume":"7","author":"Q Huang","year":"2005","unstructured":"Huang, Q., Wu, L. J., Tashiro, S., Onodera, S., Li, L. H., & Ikejima, T. (2005). Silymarin augments human cervical cancer HeLa cell apoptosis via P38\/JNK MAPK pathways in serum-free medium. Journal of Asian Natural Products Research, 7(5), 701\u2013709.","journal-title":"Journal of Asian Natural Products Research"},{"key":"9470_CR26","first-page":"707","volume":"4","author":"G Karamanlidis","year":"2011","unstructured":"Karamanlidis, G., Bautista-Hernandez, V., Fynn-Thompson, F., Del Nido, P., & Tian, R. (2011). Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circulation: Heart Failure, 4, 707\u2013713.","journal-title":"Circulation: Heart Failure"},{"key":"9470_CR27","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/495349","author":"RE Katholi","year":"2011","unstructured":"Katholi, R. E., & Couri, D. M. (2011). Left ventricular hypertrophy: Major risk factor in patients with hypertension: Update and practical clinical applications. International Journal of Hypertension. https:\/\/doi.org\/10.4061\/2011\/495349","journal-title":"International Journal of Hypertension"},{"key":"9470_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00228-011-1193-2","volume":"68","author":"S Kumphune","year":"2012","unstructured":"Kumphune, S., Chattipakorn, S., & Chattipakorn, N. (2012). Role of p38 inhibition in cardiac ischemia\/reperfusion injury. European Journal of Clinical Pharmacology, 68, 513\u2013524.","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"8","key":"9470_CR29","doi-asserted-by":"publisher","first-page":"E1287","DOI":"10.3390\/molecules22081287","volume":"22","author":"JK Lee","year":"2017","unstructured":"Lee, J. K., & Kim, N. J. (2017). Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease. Molecules, 22(8), E1287.","journal-title":"Molecules"},{"key":"9470_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/139045","author":"PC Li","year":"2012","unstructured":"Li, P. C., Chiu, Y. W., Lin, M. Y., Day, H. C., Hwang, G. Y., Pai, P., Tsai, F. J., Tsai, C. H., Kuo, Y. C., Chang, H. C., Liu, J. Y., & Huang, C. Y. (2012). Herbal supplement ameliorates cardiac hypertrophy in rats with -induced liver cirrhosis. Evidence-Based Complementary and Alternative Medicine. https:\/\/doi.org\/10.1155\/2012\/139045","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"9470_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","volume":"63","author":"JD Molkentin","year":"2001","unstructured":"Molkentin, J. D., & Dorn, G. W. (2001). Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annual Review of Physiology, 63, 391\u2013426.","journal-title":"Annual Review of Physiology"},{"issue":"1","key":"9470_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12012-017-9406-2","volume":"18","author":"BM Patel","year":"2018","unstructured":"Patel, B. M. (2018). Sodium butyrate controls cardiac hypertrophy in experimental models of rats. Cardiovascular Toxicology, 18(1), 1\u20138.","journal-title":"Cardiovascular Toxicology"},{"issue":"11","key":"9470_CR33","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1177\/0960327112446817","volume":"31","author":"BM Patel","year":"2012","unstructured":"Patel, B. M., Agarwal, S. S., & Bhadada, S.\u00a0V. (2012). Perindopril protects against streptozotocin induced hyperglycemic myocardial damage\/alterations. Human & Experimental Toxicology, 31(11), 1138\u20131149.","journal-title":"Human & Experimental Toxicology"},{"key":"9470_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pharep.2014.02.004","volume":"66","author":"BM Patel","year":"2014","unstructured":"Patel, B. M., & Desai, V. J. (2014). Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy. Pharmacological Reports, 66, 264\u2013272.","journal-title":"Pharmacological Reports"},{"key":"9470_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/10641963.2013.827699","volume":"36","author":"BM Patel","year":"2014","unstructured":"Patel, B. M., & Bhadada, S.\u00a0V. (2014). Type 2 diabetes induced cardiovascular complications: Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril. Clinical and Experimental Hypertension, 36, 340\u2013347.","journal-title":"Clinical and Experimental Hypertension"},{"key":"9470_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0033-1345168","volume":"121","author":"BM Patel","year":"2013","unstructured":"Patel, B. M., Kakadiya, J., Goyal, R. K., & Mehta, A. A. (2013). Effect of spironolactone on cardiovascular complications associated with type-2 diabetes in rats. Experimental and Clinical Endocrinology, 121, 441\u2013447.","journal-title":"Experimental and Clinical Endocrinology"},{"key":"9470_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1479164113485250","volume":"10","author":"BM Patel","year":"2013","unstructured":"Patel, B. M., Mehta, A. A. (2013). The choice of anti-hypertensive agents in diabetic subjects. Diabetes and Vascular Disease Research, 10, 385\u2013396.","journal-title":"Diabetes and Vascular Disease Research"},{"key":"9470_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.09.034","volume":"697","author":"BM Patel","year":"2012","unstructured":"Patel, B. M., & Mehta, A. A. (2012). Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases. European Journal of Pharmacology, 697, 1\u201312.","journal-title":"European Journal of Pharmacology"},{"key":"9470_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejphar.2014.01.063","volume":"728","author":"BM Patel","year":"2014","unstructured":"Patel, B. M., Raghunathan, S., & Porwal, U. (2014). Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus. European Journal of Pharmacology, 728, 128\u2013134.","journal-title":"European Journal of Pharmacology"},{"key":"9470_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2147\/CIA.S3551","volume":"3","author":"V Peppers","year":"2008","unstructured":"Peppers, V., Ramos, G., Manias, E., Koroboki, E., Rokas, S., & Zakopoulos, N. (2008). Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: A hospital-based prospective study in Greek patients. Clinical Interventions in Aging, 3, 699\u2013710.","journal-title":"Clinical Interventions in Aging"},{"key":"9470_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1534735407301632","volume":"6","author":"J Post-White","year":"2007","unstructured":"Post-White, J., Ladas, E. J., & Kelly, K. M. (2007). Advances in the use of milk thistle (Silybum marianum). Integrative Cancer Therapies, 6, 104\u2013109.","journal-title":"Integrative Cancer Therapies"},{"key":"9470_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0003-2697(60)90050-6","volume":"1","author":"DJ Prockop","year":"1960","unstructured":"Prockop, D. J., & Udenfriend, S. (1960). A specific method for the analysis of hydroxyproline in tissues and urine. Analytical Biochemistry, 1, 228\u2013239.","journal-title":"Analytical Biochemistry"},{"key":"9470_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1472-8206.2012.01051.x","volume":"27","author":"S Raghunathan","year":"2013","unstructured":"Raghunathan, S., & Patel, B. M. (2013). Therapeutic implications of small interfering RNA in cardiovascular diseases. Fundamental and Clinical Pharmacology, 27, 1\u201320.","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"9470_CR44","first-page":"179","volume":"12","author":"PR Rao","year":"2007","unstructured":"Rao, P. R., & Viswanath, R. K. (2007). Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. Experimental & Clinical Cardiology, 12, 179\u2013187.","journal-title":"Experimental & Clinical Cardiology"},{"key":"9470_CR45","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1139\/cjpp-2013-0348","volume":"92","author":"N Rayabarapu","year":"2014","unstructured":"Rayabarapu, N., & Patel, B. M. (2014). Beneficial role of tamoxifen in isoproterenol induced myocardial infarction. Canadian Journal of Physiology and Pharmacology, 92, 849\u2013857.","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"9470_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yjmcc.2012.09.002","volume":"55","author":"MG Rosca","year":"2013","unstructured":"Rosca, M. G., Tandler, B., & Hoppel, C. L. (2013). Mitochondria in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, 55, 31\u201341.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9470_CR47","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose, B. A., Force, T., & Wang, Y. (2010). Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale. Physiological Reviews, 90, 1507\u20131546.","journal-title":"Physiological Reviews"},{"key":"9470_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1043-6618(02)00252-9","volume":"47","author":"N Sakottova","year":"2003","unstructured":"Sakottova, N., Vecera, R., Urbenek, K., Vana, P., Walterova, D., & Cvak, L. (2003). Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacological Research, 47, 17\u201326.","journal-title":"Pharmacological Research"},{"key":"9470_CR49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF02709987","volume":"5","author":"V Sanz-Moreno","year":"2003","unstructured":"Sanz-Moreno, V., & Crespo, P. (2003). p38 mitogen-activated protein kinases: Their role in carcinogenesis. Revista de oncolog\u00eda, 5, 320\u2013330.","journal-title":"Revista de oncolog\u00eda"},{"key":"9470_CR50","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.physbeh.2017.07.010","volume":"179","author":"VN Thakare","year":"2017","unstructured":"Thakare, V. N., Aswar, M. K., Kulkarni, Y. P., Patil, R. R., & Patel, B. M. (2017). Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response. Physiology & Behavior, 179, 401\u2013410.","journal-title":"Physiology & Behavior"},{"key":"9470_CR51","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.pharep.2016.06.002","volume":"68","author":"VN Thakare","year":"2016","unstructured":"Thakare, V. N., Dhakane, V. D., & Patel, B. M. (2016). Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: Modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus. Pharmacological Reports, 68, 1020\u20131027.","journal-title":"Pharmacological Reports"},{"key":"9470_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0269881117742666","volume":"32","author":"VN Thakare","year":"2018","unstructured":"Thakare, V. N., Patil, R. R., Oswal, R. J., Dhakane, V. D., Aswar, M. K., & Patel, B. M. (2018). Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice. Journal of Psychopharmacology, 32, 223\u2013235.","journal-title":"Journal of Psychopharmacology"},{"key":"9470_CR53","first-page":"239","volume":"47","author":"M Tsimaratos","year":"2001","unstructured":"Tsimaratos, M., Coste, T. C., Djemli-Shipkolye, A., Daniel, L., Shipkolye, F., Vague, P., & Raccah, D. (2001). Evidence of time-dependent changes in renal medullary Na,K-ATPase activity and expression in diabetic rats. Cellular Molecular Biology (Noisy-le-grand), 47, 239\u2013245.","journal-title":"Cellular Molecular Biology (Noisy-le-grand)"},{"issue":"1","key":"9470_CR54","first-page":"36","volume":"28","author":"MJ Tuorkey","year":"2015","unstructured":"Tuorkey, M. J., El-Desouki, N. I., & Kamel, R. A. (2015). Cytoprotective effect of Silymarin against diabetes-induced cardiomyocyte apoptosis in diabetic rats. Biomedical and Environmental Sciences, 28(1), 36\u201343.","journal-title":"Biomedical and Environmental Sciences"},{"key":"9470_CR55","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1074\/jbc.273.4.2161","volume":"273","author":"Y Wang","year":"1998","unstructured":"Wang, Y., Huang, S., Sah, V. P., Ross, J., Brown, J. H., Han, J., & Chien, K. R. (1998). Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. Journal of Biological Chemistry, 273, 2161\u20132168.","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"9470_CR56","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/hq0302.105287","volume":"22","author":"JH Wu","year":"2002","unstructured":"Wu, J. H., Hagaman, J., Kim, S., Reddick, R. L., & Maeda, N. (2002). Aortic constriction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E. Arteriosclerosis, Thrombosis, and Vascular Biology, 22(3), 469\u2013475.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9470_CR57","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1172\/JCI16290","volume":"111","author":"S Zhang","year":"2003","unstructured":"Zhang, S., Weinheimer, C., Courtois, M., Kovacs, A., Zhang, C. E., Cheng, A. M., Wang, Y., & Muslin, A. J. (2003). The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. Journal of Clinical Investigation, 111, 833\u2013841.","journal-title":"Journal of Clinical Investigation"},{"key":"9470_CR58","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.fitote.2014.05.016","volume":"97","author":"A Zholobenko","year":"2014","unstructured":"Zholobenko, A., & Modriansky, M. (2014). Silymarin and its constituents in cardiac preconditioning. Fitoterapia, 97, 122\u2013132.","journal-title":"Fitoterapia"},{"issue":"6","key":"9470_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1745-7254.2007.00472.x","volume":"28","author":"B Zhou","year":"2007","unstructured":"Zhou, B., Wu, L. J., Tashiro, S., Onodera, S., Uchiumi, F., & Ikejima, T. (2007). Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent. Acta Pharmacologica Sinica, 28(6), 803\u2013810.","journal-title":"Acta Pharmacologica Sinica"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-018-9470-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-018-9470-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-018-9470-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T13:56:15Z","timestamp":1751723775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-018-9470-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9470"],"URL":"https:\/\/doi.org\/10.1007\/s12012-018-9470-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,2]]},"assertion":[{"value":"2 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}